Recombinant Vaccines Market Size to Hit USD 32.83 Billion by 2032, Driven by Rising Global Incidence of Infectious Diseases
05. September 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Sept. 05, 2024 (GLOBE NEWSWIRE) -- "According to SNS Insider, The Recombinant Vaccines Market Size was valued at USD 12.53 Billion in 2023 and is expected to reach USD 32.83 Billion by 2032...
Shingles Vaccine Market Size to Reach US$ 5.97 billion, with a CAGR of 8.2% By 2034
30. Juli 2024 08:13 ET
|
FACT.MR
Rockville, MD, July 30, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, the global shingles vaccine market size is estimated at a value of US$ 2.71 billion in 2024...
Recombinant Vaccines Market to Cross USD 21.46 Billion by 2030 Owing to Technological Advancements in Vaccine Development | Research by SNS Insider
03. Oktober 2023 09:00 ET
|
SNS Insider pvt ltd
Pune, Oct. 03, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report states that the Recombinant Vaccines Market reached USD 9.18 billion in 2022 and is projected to attain USD 21.46 billion by 2030,...
Global Recombinant Vaccines Market Is Expected to Reach $24.7 Billion by 2031: Says AMR
21. Oktober 2022 11:30 ET
|
Allied Market Research
Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Recombinant Vaccines Market generated $8.1 billion in 2021 and is estimated to...
At 11.3% CAGR, Recombinant Vaccines Market Size [2021-2028] | is Expected to Reach USD 25.32 Billion
16. Dezember 2021 06:28 ET
|
Fortune Business Insights
Pune, India, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The global recombinant vaccines market size is expected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% between 2019 to 2027. The...
Recombinant Vaccines Market to Reach USD 25.32 Billion by 2027; Increasing Prevalence of Human Papillomavirus Disease to Brighten Business Prospects, states Fortune Business Insights™
18. August 2020 11:15 ET
|
Fortune Business Insights
Pune, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The global recombinant vaccines market size is expected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% between 2019 to 2027. The...
Recombinant Vaccines Market to Reach $21 Billion by 2026; Increasing Number of Regulatory Approvals to Aid Growth, says Fortune Business Insights™
13. Januar 2020 07:57 ET
|
Fortune Business Insights
Pune, Jan. 13, 2020 (GLOBE NEWSWIRE) -- The global Recombinant Vaccines Market size is projected to reach USD 21.00 billion by the end of 2026. The advancements in molecular genomics have opened up...
Novel Recombinant Vaccines for New Indications Creating Lucrative Opportunities in the Global Market - Future Market Insights
05. Dezember 2018 08:30 ET
|
Future Market Insights
VALLEY COTTAGE, N.Y., Dec. 05, 2018 (GLOBE NEWSWIRE) -- A new study by the company titled 'Recombinant Vaccines Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', has...